These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19303203)

  • 1. Why doesn't high-dose chemotherapy improve survival, as was expected, in advanced or relapsed germ cell tumours?
    Pizzocaro G; Guarneri A
    Eur Urol; 2009 Jul; 56(1):46-7. PubMed ID: 19303203
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of poor-prognosis or relapsed germ-cell cancer.
    Daugaard G
    BJU Int; 2009 Nov; 104(9 Pt B):1392-7. PubMed ID: 19840019
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review.
    Connolly RM; McCaffrey JA
    Eur Urol; 2009 Jul; 56(1):57-64. PubMed ID: 19303697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV; Bacik J; Donadio A; Bajorin D; Marion S; Sheinfeld J; Bosl GJ; Motzer RJ
    J Clin Oncol; 2005 Sep; 23(27):6549-55. PubMed ID: 16170162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of recurrent testicular germ cell tumors.
    Sonpavde G; Hutson TE; Roth BJ
    Oncologist; 2007 Jan; 12(1):51-61. PubMed ID: 17227900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage chemotherapy after failure of first-line chemotherapy in patients with metastatic testicular cancer.
    Kollmannsberger C; Bokemeyer C
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):167-72. PubMed ID: 18685416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin.
    Brada M; Horwich A; Peckham MJ
    Cancer Treat Rep; 1987 Jun; 71(6):655-6. PubMed ID: 2438041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
    Rick O; Siegert W; Beyer J
    Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germ-cell tumors.
    Shamash J; Stebbing J; Powles T
    N Engl J Med; 2007 Oct; 357(17):1771-2; author reply 1773-4. PubMed ID: 17960020
    [No Abstract]   [Full Text] [Related]  

  • 14. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
    Margolin K
    J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pathologic analysis of lesions following modern chemotherapy for metastatic germ-cell tumors.
    Ulbright TM; Roth LM
    Pathol Annu; 1990; 25 Pt 1():313-40. PubMed ID: 2153278
    [No Abstract]   [Full Text] [Related]  

  • 16. Germ-cell tumors.
    Lorch A; Beyer J; Bokemeyer C
    N Engl J Med; 2007 Oct; 357(17):1772-3; author reply 1773-4. PubMed ID: 17969228
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Roisin M. Connolly, John A. McCaffrey. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review. Eur Urol 2009;56:57-64.
    Necchi A; Nicolai N; Salvioni R
    Eur Urol; 2010 Jan; 57(1):e5-6. PubMed ID: 19818550
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer stem cell in relapsed testicular germ cell cancer: embryonic or somatic?
    Mego M
    Int J Androl; 2006 Dec; 29(6):627. PubMed ID: 17073946
    [No Abstract]   [Full Text] [Related]  

  • 19. Germ-cell tumors.
    De Giorgi U; Pedrazzoli P; Rosti G; ;
    N Engl J Med; 2007 Oct; 357(17):1773; author reply 1773-4. PubMed ID: 17969230
    [No Abstract]   [Full Text] [Related]  

  • 20. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
    Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
    Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.